TEAD3 Gene: TEA Domain Transcription Factor 3

Key regulator of Hippo signaling pathway and transcriptional coactivator in development and cancer

Gene Information Card

Symbol TEAD3
Full Name TEA Domain Transcription Factor 3
Gene Type Protein coding
Chromosomal Location 6p21.31
NCBI Gene ID 7005 ncbi.nlm.nih.gov/gene/7005
Ensembl ID ENSG00000112210
UniProt ID Q99594
OMIM ID 603170
HGNC ID 11715
Aliases DTEF-1, TEAD-3, TEF-5

Description

TEAD3 (TEA Domain Transcription Factor 3) is a member of the TEAD family of transcription factors, which share a conserved TEA/ATTS DNA-binding domain. TEAD3 binds to the MCAT element (5'-CATTCCT-3') in the promoters of target genes and acts as a nuclear effector of the Hippo signaling pathway by interacting with YAP1 and WWTR1/TAZ coactivators. It plays critical roles in embryonic development, cell proliferation, and organ size control. TEAD3 is expressed in multiple tissues, including placenta, heart, and skeletal muscle.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) TEAD3 overexpression or aberrant activation via Hippo pathway dysregulation promotes cell proliferation and tumorigenesis COSMIC, ClinVar
Developmental disorders TEAD3 mutations may disrupt Hippo signaling, affecting organogenesis and growth OMIM
Cardiovascular disease TEAD3 regulates cardiac gene expression; altered activity linked to heart development defects NCBI Gene, UniProt

Expression Profile

Tissue Expression
Tissue nTPM level
Placenta 12.5 High
Heart 8.3 Medium
Skeletal muscle 6.1 Medium
Lung 4.2 Low
Brain 2.8 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 15.2 High expression in embryonic kidney cells
HeLa 9.7 Moderate expression in cervical cancer cells
MCF7 7.4 Moderate expression in breast cancer cells
A549 5.1 Low expression in lung cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.101C>T (p.Pro34Leu) Missense Rare Unknown functional impact; reported in ClinVar
c.457G>A (p.Val153Met) Missense Rare Potential loss of DNA binding; limited evidence
c.1120_1121insA (p.Thr374Asnfs*5) Frameshift Very rare Predicted loss of function; truncation of C-terminal domain
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the protein, impairing DNA binding or YAP/TAZ interaction, are classified as loss-of-function.

Gain of Function (GOF)

Missense mutations that enhance TEAD3 stability or coactivator binding may act as gain-of-function, but specific examples are not well documented.

Dominant Negative (DN)

Mutations that retain DNA binding but fail to activate transcription could act as dominant-negative, though no confirmed cases are reported.

Pathways

Hippo signaling pathway (KEGG: hsa04390)
Transcriptional regulation by TEAD factors (Reactome: R-HSA-8953854)
YAP/TAZ coactivator signaling (Reactome: R-HSA-2028269)

Protein Summary

TEAD3 encodes a 435-amino acid protein containing an N-terminal TEA DNA-binding domain and a C-terminal transactivation domain that interacts with YAP1 and WWTR1/TAZ. The protein functions as a transcription factor that regulates genes involved in cell proliferation, differentiation, and organ size control. TEAD3 is ubiquitously expressed with highest levels in placenta, heart, and skeletal muscle. Post-translational modifications include phosphorylation and acetylation, which modulate its activity. TEAD3 is implicated in cancer and developmental disorders through dysregulation of Hippo signaling.

Related Products

Product name Cat.No. Species Gene ID
TEAD3 Knockout HEK293 Cell Line EDJ-KQ947 Human 7005 Details Get a Quote
TEAD3 Knockout A-549 Cell Line EDJ-KQ19933 Human 7005 Details Get a Quote
TEAD3 Knockout HCT 116 Cell Line EDJ-KQ19934 Human 7005 Details Get a Quote
TEAD3 Knockout HeLa Cell Line EDJ-KQ19935 Human 7005 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: